(Q46647061)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Johannes-Matthias Löhr

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Samel S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Keese M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Lux A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jesnowski R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Prosst R

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Saller R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Hafner M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sturm J

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Post S

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

65-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700849

5 January 2020

exact match

0 references

cites work

Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Natural history of peritoneal carcinomatosis from nongynecologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

New responsibilities in the management of colorectal cancer with peritoneal seeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Influence of TNFA on the formation of liver metastases in a syngenic mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Enhanced green fluorescent protein-transfection of murine colon carcinoma cells: key for early tumor detection and quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Microencapsulation of genetically engineered cells for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Systemic vs local administration of delta-aminolevulinic acid for laparoscopic fluorescence diagnosis of malignant intra-abdominal tumors. Experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Treatment and prevention of peritoneal carcinomatosis from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

The etiology, clinical presentation, and management of pseudomyxoma peritonei

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Intraperitoneal antineoplastic drug delivery: rationale and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Use of replication-conditional adenovirus as a helper system to enhance delivery of P450 prodrug-activation genes for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

A murine model of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

A Microassay for Measuring Cytochrome P450IA1 and Cytochrome P450IIB1 Activities in Intact Human and Rat Hepatocytes Cultured on 96-Well Plates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(L)lysine-alginate (APA) membrane following allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Intratumoral injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Peritoneal mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Green fluorescent protein immunohistochemistry as a novel experimental tool for the detection of glioma cell invasion in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Noninvasive fluorescent imaging reliably estimates biomass in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700849

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700849

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16096652%20AND%20SRC:MED&resulttype=core&format=json

release_wngvdiugh5aupakxdfm5l7le34

5 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wngvdiugh5aupakxdfm5l7le34

24 November 2022

mapped directly with Wikidata item

1 reference